Joining VUMC as a co-leaders are groups from Brigham and Women’s Hospital in Boston, Duke Clinical Research Institute in Durham, N.C., and Kaiser Permanente Washington Health Research Institute in Seattle. The innovation center will focus on leveraging de-identified data from EHRs and publicly available data sources to enhance medical product safety surveillance. The center comprises more than 50 academic centers and healthcare payers.
“The Innovation Center will support VUMC and its other member organizations in the development of new tools to efficiently unlock the safety information in these records — tools in areas like natural language processing, machine learning and safety signal detection,” said Michael Matheny, MD, associate bioinformatics professor at VUMC and a member of the Innovation Center executive committee, according to the report.
The FDA launched Sentinel in 2009 to oversee surveillance of medical products after they have reached market. Products include drugs, medical devices, vaccines and biologicals.
Boston-based Harvard Pilgrim Health Care Institute oversees Sentinel operations. The institute recently partnered with Veradigm, Allscripts’ payer and life sciences division, to extract and structure information from EHRs for the Sentinel drug safety database.
More articles on innovation:
Mayo Clinic innovation leader Dr. Douglas Wood: ‘There is no innovation without action’
Froedtert & the Medical College of Wisconsin publicly launch $225M innovation campaign
Valley Children’s Healthcare launches innovation program
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
